Edison Investment Research - Solon Eiendom ASA (SOLON) Outlook: Boost for Vacc-4x

Report

Edison Investment Research

Outlook: Boost for Vacc-4x

Encouraging data from the â€˜Kill and Boostâ€™ trial have confirmed that the combination of Vacc-4x with an immune modulator (lenalidomide) can increase CD4 counts. Bionor now plans to discuss these, and the elite responder data, with regulators to validate potential future development options for Vacc-4x. The REDUC â€˜Kick & Killâ€™ trial is also ongoing with data expected in 2015, which will be key for the functional cure strategy.

01/12/2014 12 EN

Underlying

Solon Eiendom ASA

Solon Eiendom is a biotechnology company. Co.'s focus is the research and development of peptide based vaccines against viral diseases, primarily human immunodeficiency virus (HIV). As of Dec 31 2013, Co.'s clinical development pipeline comprised of two vaccine candidates for the treatment of HIV, Vacc-4X and Vacc-C5. Vacc-4X is being investigated in two phases II trials in collaboration with Celgene Inc.

See profile

NO0003106700 Oslo Bors Norway

Provider

Edison Investment Research

Edison is an investment research and advisory company, with offices in North America, Europe, the Middle East and AsiaPac. The heart of Edison is our world renowned equity research platform and deep multi-sector expertise. At Edison Investment Research, our research is widely read by international investors, advisors and stakeholders. Edison Advisors leverages our core research platform to provide differentiated services including investor relations and strategic consulting.

See profile

Other Reports on these Companies

ABG Sundal Collier

Solon Eiendom - Terminating coverage

ABGSC terminates coverage of Solon Eiendom… …following its acquisition by SBB Last published estimates are shown in this report

January 17, 2022 January 17, 2022 1 EN

DnB Markets

Changes ahead on the new EU Green Deal White Paper

Green building-code regulations have so far targeted only newbuilds and some large renovations; however, a recent EC White Paper aims to regulate and speed up the renovation and modernisation of existing buildings. The EC is initially targeting the worst-performing 15% of building stock (requiring an upgrade from energy class G to at least F). While we expect the impact of the new regulation to be limited in our forecast period, we have raised our long-term growth assumptions and changed our sector stance to overweight (neutral).

Free Trial

January 15, 2022 January 15, 2022 1 EN

DnB Markets

Solon Eiendom (No_rec, TP: NOK) - Discontinuing coverage

Discontinuing coverage

Free Trial

January 3, 2022 January 3, 2022 1 EN

Manx Financial Group - Termination of coverage

Edison Investment Research is terminating coverage on Manx Financial Group (MFX). Please note you should no longer rely on any previous research or estimates for this company. All forecasts should now be considered redundant. Previously published reports can still be accessed via our website.

March 10, 2025 March 10, 2025 1 EN

Kate Heseltine

Kate Heseltine

musicMagpie - Termination of coverage

Edison Investment Research is terminating coverage on musicMagpie (MMAG). Please note you should no longer rely on any previous research or estimates for this company. All forecasts should now be considered redundant. Previously published reports can still be accessed via our website.

March 5, 2025 March 5, 2025 1 EN

Kate Heseltine

Kate Heseltine

Topps Tiles - Accelerating growth through Q125

Topps Tiles (TPT) is enjoying a return to revenue growth following a very challenging FY24 due to wider macroeconomic weakness. The company’s recovery is clearly being boosted by new revenue streams from its self-help initiatives, notably from trade and online customers across all of its brands. While the macroeconomic environment remains uncertain, it is pleasing that the strategy is supporting growth. The valuation continues to look compelling, even with limited macroeconomic recovery included in management’s long-term financial goals. With the Q125 trading update, the CEO has announced his ...

January 10, 2025 January 10, 2025 1 EN

Sign-up for free to access full reports immediately

Email Address*

Choose Password* ( 6 or more characters )

Due to regulatory restrictions regarding the distribution of financial research, this report is restricted to a specific region or investor type. Get access to exclusive reports by answering the questions below.

Select your country*

Get financial insights straight to your inbox

By clicking "register" you accept the Terms and Conditions & Privacy Policy

Already on ResearchPool?

Almost there...

Are you a professional investor?

Select your country

REGISTER

Create a free ResearchPool account to access full reports, get a personalised dashboard and follow providers or companies

In order to access this report please create an account.

LOGIN